Noncolorectal Gastrointestinal Cancer Journal Articles
- Treating Borderline Resectable Pancreatic Cancer
- Non-invasive Fibrosis Markers in Chronic Hepatitis Delta
- Higher Mortality Among Lean Patients With NAFLD
- The Need for Efficient, Patient-oriented NASH Drug Development
- Mortality Risk Factors Following SVR After DAAs for HCV
- Real-World Data on Severe Lung Cancer
- Lower Birthweight and NAFLD: Role of Insulin Resistance
- Secondary Bile Acids Identify Mild Liver Fibrosis in NAFLD
- ICI-Induced Arthralgia Improves Survival in Cancer Patients
- Light-to-moderate Alcohol Consumption and Progressive NAFLD
- Late-Onset Rejection in Liver Allograft Biopsies
- Palliative Interventions for Advanced Gastric Cancer
- Extra-hepatic Morbidity and Mortality in ALD
- The Impact of the COVID-19 Pandemic on Urologic Cancer Care
- Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC
- Immunotherapy in HCC: Influence of Underlying Liver Disease
- Prediction of Advanced Liver Fibrosis in CHB Patients With NAFLD
- Vigorous Exercise Protects Against All-Cause Deaths in NAFLD
- MAFLD Identifies Subjects With CVD Risk Better Than NAFLD
- Chemoprevention of HCC With Statins, Aspirin and Metformin